Pennsylvania Drops K-Dur Antitrust Suit

Law360, New York (August 30, 2007, 12:00 AM EDT) -- Pennsylvania has dropped its lawsuit against health care giants Schering-Plough Corp., Upsher-Smith Laboratories Inc. and Wyeth Pharmaceuticals Inc., which accused them of striking a pact to keep the generic version of heart drug K-Dur 20 from reaching the market.

The Commonwealth of Pennsylvania on Wednesday submitted a stipulation to dismiss its case against the companies, along with Schering-Plough subsidiary Key Pharmaceuticals Inc. and Wyeth unit ESI-Lederle Inc., with prejudice.

Pennsylvania's lawsuit against the companies, over the sale of Schering-Plough's brand-name prescription heart medication K-Dur 20, was...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.